Warning: The NCBI web site requires JavaScript to function. more...
Generate a file for use with external citation management software.
Department of Pharmacy Practice, Family and Community Medicine, Area Health Education Center-Northeast, University of Arkansas for Medical Sciences, Jonesboro, AR, USA. dcummins@ahecne.uams.edu
Simvastatin is a cholesterol-lowering medication heavily prescribed to treat and prevent vascular disease. Despite widespread use, cases of simvastatin-induced rhabdomyolysis are rare. Little information is available regarding the recovery period for a patient who has experienced drug-induced rhabdomyolysis. We present a case involving a patient with multiple risk factors (advanced age, high-dose simvastatin therapy, concomitant nonsteroidal anti-inflammatory medication, and concomitant gemfibrozil therapy) and highlight his recovery course.
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on